I denne underholdende og tankevækkende aktualitetspodcast debatterer og analyserer Børsens chefredaktør, Bjarne Corydon, og ...
Lars Fruergaard Jørgensen might not be a household name, but his company’s drug Ozempic is. And its success has thrust him — ...